Track topics on Twitter Track topics that are important to you
Palforzia, a peanut allergen powder, has been approved for the reduction of allergic reactions in children aged four to 17. It is not an emergency treatment but instead designed to build tolerance.
The post FDA approves Palforzia for treatment of peanut allergy in children appeared first on European Pharmaceutical Review.
Original Article: FDA approves Palforzia for treatment of peanut allergy in childrenNEXT ARTICLE
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...